日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

mTOR dysregulation induces IL-6 and paracrine AT2 cell senescence impeding lung repair in lymphangioleiomyomatosis

mTOR失调诱导IL-6和旁分泌AT2细胞衰老,从而阻碍淋巴管肌瘤病中的肺修复。

Babaei-Jadidi, Roya; Clements, Debbie; Wu, Yixin; Chen, Ken; Miller, Suzanne; Platé, Manuela; Lim, Kyungtae; Rue, Ryan; Krymskaya, Vera P; Chambers, Rachel; Rawlins, Emma L; Xu, Yan; Johnson, Simon R

The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in Lymphangioleiomyomatosis.

双位阻抑制剂 RMC-5552 可降低淋巴管肌瘤病中的 mTORC1 信号传导和生长

Evans Jilly F, Ledwell Owen A, Tang Yan, Rue Ryan, Mukhitov Alexander R, Diesler Rémi, Lin Susan M, Vanka Kanth Swaroop, Basil Maria C, Cantu Edward, Henske Elizabeth P, Krymskaya Vera P

Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis.

将尼他唑尼用于治疗罕见病淋巴管肌瘤病

Bähr Stella, Rue Ryan W, Smith Carly J, Evans Jillian F, Köster Hubert, Krymskaya Vera P, Pleimes Dirk

Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex

靶向DGKA介导的巨胞饮作用可导致结节性硬化症复合体中的磷脂重编程

Kovalenko, Andrii; Sanin, Andres; Kosmas, Kosmas; Zhang, Long; Wang, Ji; Akl, Elie W; Giannikou, Krinio; Probst, Clemens K; Hougard, Thomas R; Rue, Ryan W; Krymskaya, Vera P; Asara, John M; Lam, Hilaire C; Kwiatkowski, David J; Henske, Elizabeth P; Filippakis, Harilaos

Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells

在Tsc2基因敲除小鼠胚胎成纤维细胞和人淋巴管肌瘤病细胞中,IGF2表达不依赖于雷帕霉素。

Himes, Blanca E; Obraztsova, Kseniya; Lian, Lurong; Shumyatcher, Maya; Rue, Ryan; Atochina-Vasserman, Elena N; Hur, Stella K; Bartolomei, Marisa S; Evans, Jilly F; Krymskaya, Vera P